SCHEMBL4640476

SCHEMBL4640476

CCCCC(CCC(C)C)OC(=O)c1cccc(I)c1C(=O)O

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.44
CYP3A4 P08684 2/20 0.36
CA2 P00918 1/20 0.36
CTSK P43235 4/20 0.36
SCN1A P35498 1/20 0.36
SCN2A Q99250 1/20 0.36
SCN3A Q9NY46 1/20 0.36
SLC37A4 O43826 1/20 0.35
PRKCA P17252 1/20 0.35
PRKCD Q05655 1/20 0.35
KDM4E B2RXH2 2/20 0.34
MEN1 O00255 1/20 0.34
RECQL P46063 1/20 0.34
KMT2A Q03164 1/20 0.34
LMNA P02545 1/20 0.34
TSHR P16473 3/20 0.33
TDP1 Q9NUW8 1/20 0.33
L3MBTL1 Q9Y468 1/20 0.33
PTPN1 P18031 1/20 0.33
PPARA Q07869 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4640474 0.93 ALDH1A1 (0.41) ALDH1A1CYP3A4CA2CTSKSCN1A
SCHEMBL4640708 0.89 ALDH1A1 (0.39) ALDH1A1CA2SCN1ASCN2ASCN3A
SCHEMBL4640981 0.87 ALDH1A1 (0.45) ALDH1A1CYP3A4CA2SCN1ASCN2A
SCHEMBL4640132 0.87 ALDH1A1 (0.45) ALDH1A1CYP3A4CA2CTSKSCN1A
SCHEMBL4640018 0.86 ALDH1A1 (0.44) ALDH1A1CYP3A4CA2CTSKSCN1A
SCHEMBL4640543 0.86 ALDH1A1 (0.44) ALDH1A1CYP3A4CA2CTSKSCN1A
SCHEMBL4641125 0.86 ALDH1A1 (0.44) ALDH1A1CYP3A4CA2CTSKSCN1A
SCHEMBL4642716 0.84 ALDH1A1 (0.43) ALDH1A1CYP3A4CA2CTSKSCN1A
SCHEMBL4639931 0.83 ALDH1A1 (0.46) ALDH1A1CYP3A4CA2CTSKSLC37A4
SCHEMBL233630 0.83 ALDH1A1 (0.64) ALDH1A1CYP3A4CA2CTSKSCN1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1188739-B1 PHTHALIC DIESTER DERIVATIVES AND ELECTRON DONORS TOHO TITANIUM CO LTD (JP) 2008-08-13 EP disclosed
US-6670497-B2 Dialkyl (at least one of which is a C4-8 tertiary alkyl) ester of an alkyl- or halo-substituted phthalic acid; used in an olefin polymerization catalyst TOHO TITANIUM CO., LTD. (JP) 2003-12-30 US disclosed
US-20030036594-A1 Phthalic diester derivatives and electron donors TOHO TITANIUM CO., LTD. (JP) 2003-02-20 US disclosed
EP-1188739-A1 PHTHALIC DIESTER DERIVATIVES AND ELECTRON DONORS TOHO TITANIUM CO., LTD. (JP) 2002-03-20 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030036594-A1 Phthalic diester derivatives and electron donors HPD, ETFA, PPOX ALDH1A1 725/4885CYP3A4 424/4885CA2 2590/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.